Table 1. Clinical and demographic data of patients suspected of VL, distributed as case and controls after lymph node aspirate microscopy, participating in this study.
| Controls, n = 101 (%) | Cases, n = 97 (%) | |
|---|---|---|
| Study site | ||
| IEND | 18 (17.8%) | 24 (24.7%) |
| Bazoura | 83 (82.2%) | 73 (75.3%) |
| Female | 48 (47.5%) | 27 (27.8%) |
| Male | 53 (52.5%) | 70 (72.2%) |
| Age (years) | ||
| < 5 | 4 (3.9) | 11 (11.3) |
| 5–15 | 34 (33.7) | 43 (44.3) |
| 16–40 | 52 (51.5) | 37 (38.2) |
| 41–60 | 9 (8.9) | 5 (5.2) |
| >60 | 2 (2.0) | 1 (1.0) |
| Fever > 2 weeks | 101 (100) | 97 (100) |
| Lymphadenopathy | 67 (66.3) | 87 (89.7) |
| Splenomegaly | 35 (34.7) | 87 (89.7) |
| Mean spleen size (cm) | 3.8 | 8.2 |
| Hepatomegaly | 22 (21.8) | 64 (66.0) |
| Mean liver size (cm) | 3 | 3 |
| Weight loss | 45 (44.5) | 53 (54.6) |
| Mean haemoglobin count (g/dl) | 9.5 | 8.3 |
| Jaundice | 7 (6.9) | 17 (17.5) |
| Cough | 23 (22.8) | 46 (47.4) |